Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
Kathleen Settle(University of Maryland, Baltimore), Kevin J. Cullen(University of Maryland, Baltimore), Scott E. Strome(Mayo Clinic), Ming Tan(University of Maryland, Baltimore), Nicholas J. Sarlis(Incyte (United States)), Shital S. Patel(University of Maryland, Baltimore), Earl V. Cambell(University of Maryland, Baltimore), Robert I. Haddad(Georgetown University), Lisa M. Schumaker, Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Jochen H. Lorch(Northwestern University), Mohan Suntharalingam(University of Maryland, Baltimore), Olga Goloubeva(University of Maryland, Baltimore)
Cited by 297
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926